The investigators sought to evaluate the feasibility and safety of surgical sympathetic blockade in systolic heart failure patients and secondary to assess its cardiovascular consequences.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
15
Left cervico-thoracic sympathetic blockade by videothoracoscopic clipping under general anesthesia and single-lumen orotracheal intubation in semi-sitting position.
Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
São Paulo, São Paulo, Brazil
Perioperative mortality and morbidity
Study interruption criteria: * death attributable to surgical procedure; * cardiogenic shock attributable to surgical procedure; * worsening of heart failure symptoms attributable to surgical procedure; * Horner's syndrome * hypotension or bradiarrhythmia attributable to surgical procedure
Time frame: 30 days after operation
Cardiovascular effects
* left ventricle ejection fraction (echo and gated blood pool) * end left ventricle diastolic diameter * mean heart rate * heart rate variability * New York Heart Association functional class * Minesotta Living with Heart Failure Questionnaire Score * peak oxygen consumption * walked distance in 6 minute walking test * BNP * 123-I-Metaiodobenzylguanidine (late heart/mediastinum ratio) * sympathetic peripheral nerve activity (microneurography) * baroreflex parameters (low and high frequency)
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.